The Alvin J. Siteman Cancer Center (SCC) at Washington University and Barnes-Jewish Hospital is a NCI designated Comprehensive Cancer Center whose mission is to prevent cancer in the community and transform cancer patient care through scientific discovery. SCC accomplishes this mission through strong research programs, shared resource support, education and training, pilot funding programs, and community outreach. The translational research and scientific discovery facilitated by our seven multidisciplinary research programs and 10 shared resources (11th requested in this application) is driven by the needs of patients in our 82-county catchment area throughout Missouri and southern Illinois. The center applies the exceptional talent among our 230 members, from four schools and 23 departments, to further understand the mechanisms of cancer pathways, speed the conduit from bench to bedside, and implement prevention strategies that impact cancer screening, incidence, and mortality in our catchment area. SCC?s Breast Cancer Research, Hematopoietic Development and Malignancy, Mechanisms of Cancer Biology, Oncologic Imaging, Prevention and Control, Solid Tumor Therapeutics, and Tumor Immunology Research Programs promote novel, multidisciplinary cancer research and encourage intra, inter, and cross- institution collaboration. Success is evidenced by SCC?s key metrics in the project period; data below are current as of this application and each represents an all-time high for the center: ? NCI funding ? $41.0M direct, excluding CCSG dollars ? Number of large collaborative grants ? 72 ? Interventional clinical trial accruals ? 5,071 in 2018 ? Total cancer-focused publications ? 1,148 in 2018; 35% intra- or inter-programmatic ? High Impact Publications ? 201 in 2018 (> 10.0 IF) In the next five years, SCC will advance its mission through exceptional research and clinical care, with special emphasis on four overarching scientific themes chosen to optimally harness and magnify the center?s impact on cancer in the field and in our catchment. These scientific pillars are: genomics and its application to clinical care; innovation in imaging technologies and their use in cancer diagnosis and treatment; immunology and the enhancement of patient care using unique immune therapies; and prevention, to reduce the burden of disease in the population of patients we serve. These core strengths align with SCC?s current strategic plan and inform research program aims, objectives, and initiatives.

Public Health Relevance

The Alvin J. Siteman Cancer Center (SCC) at Washington University and Barnes-Jewish Hospital is a NCI designated Comprehensive Cancer Center whose mission is to prevent cancer in the community and transform cancer patient care through scientific discovery. SCC accomplishes this mission through strong research programs, shared resource support, education and training, pilot funding programs, and community outreach. The translational research and scientific discovery facilitated by our seven multidisciplinary research programs and 10 shared resources (11th requested in this application) is driven by the needs of patients in our 82-county catchment area throughout Missouri and southern lllinois.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA091842-19
Application #
10021360
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Roberson, Sonya
Project Start
2001-08-02
Project End
2025-06-30
Budget Start
2020-07-15
Budget End
2021-06-30
Support Year
19
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Washington University
Department
Surgery
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Cherian, Mathew A; Olson, Sydney; Sundaramoorthi, Hemalatha et al. (2018) An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia. J Biol Chem 293:6844-6858
Smith, Lee; Ae Lee, Jung; Mun, Junbae et al. (2018) Levels and patterns of self-reported and objectively-measured free-living physical activity among prostate cancer survivors: A prospective cohort study. Cancer :
Burclaff, Joseph; Mills, Jason C (2018) Plasticity of differentiated cells in wound repair and tumorigenesis, part II: skin and intestine. Dis Model Mech 11:
Ekenga, Christine C; Pérez, Maria; Margenthaler, Julie A et al. (2018) Early-stage breast cancer and employment participation after 2 years of follow-up: A comparison with age-matched controls. Cancer 124:2026-2035
Lin, Huawen; Guo, Suyang; Dutcher, Susan K (2018) RPGRIP1L helps to establish the ciliary gate for entry of proteins. J Cell Sci 131:
Parikh, Rajiv P; Myckatyn, Terence M (2018) Paravertebral blocks and enhanced recovery after surgery protocols in breast reconstructive surgery: patient selection and perspectives. J Pain Res 11:1567-1581
Duan, Chong; Kallehauge, Jesper F; Pérez-Torres, Carlos J et al. (2018) Modeling Dynamic Contrast-Enhanced MRI Data with a Constrained Local AIF. Mol Imaging Biol 20:150-159
Zigler, Rachel E; Madden, Tessa; Ashby, Caitlin et al. (2018) Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users: A Randomized Controlled Trial. Obstet Gynecol 132:888-894
Murali, Bhavna; Ren, Qihao; Luo, Xianmin et al. (2018) Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss. Cancer Res 78:5618-5630
Ahmad, Fahd A; Jeffe, Donna B; Plax, Katie et al. (2018) Characteristics of youth agreeing to electronic sexually transmitted infection risk assessment in the emergency department. Emerg Med J 35:46-51

Showing the most recent 10 out of 1244 publications